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To the Editor: In measured plasma levels of short-chain fatty acids in Reye's syndrome, McArthur et al 1 found a significant increase only of propionic acid levels in patients with moderate or severe clinical signs, and of isovaleric acid concentrations in patients with moderate signs; isobutyric, n-butyric, n-valeric and caproic acid concentrations showed no elevation, but tended to values lower than those of controls. Of these six acids, increased levels of only isovaleric and propionic acids occur in disorders of biotin-dependent carboxylases. Isovaleric acid is elevated in cases of diminished activity of 3-methylcrotonyl-CoA carboxylase; propionic acid is elevated in propionyl-CoA carboxylase deficiency. 2 The most prominent finding* in a postmortem examination of mitochondrial liver enzymes in patients with Reye's syndrome was reduction of pyruvate carboxylase activity, another bio tindependent carboxylase, and this could explain the lactic acidemia of Reye's syndrome. 1 - 4 We found a marked reduction of plasma levels of biotin (caused by intake of anticonvulsants) and elevation of biotin-dependent short-chain fatty acids in the urine of seizure patients. r,ß Because Reye's syndrome is sometimes a fatal complication of anticonvulsant therapy, 7 the possible relation between biotin status or biotin-dependent carboxylases should be considered in investigations of Reye's syndrome.
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